NOVN.SW
Novartis AG News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 2,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "8b0810ac-b461-48b7-9a23-abb5ed1a642f",
"title": "Jeremy Grantham's Strategic Moves in Q1 2024: A Closer Look at Alphabet Inc's Impact",
"description": "Insights into Grantham's Latest 13F Filings and Portfolio Adjustments\n\nJeremy Grantham (Trades, Portfolio), the Chairman of the Board at Grantham Mayo van Otter",
"keywords": "GuruFocus, Article, News, GuruFocus Research, MSFT, GOOGL, META, UNH, AAPL, X, MGRC, GEHC, SPLK, PNM, CSIQ, NVS",
"snippet": "Insights into Grantham's Latest 13F Filings and Portfolio Adjustments\n\nJeremy Grantham (Trades, Portfolio), the Chairman of the Board at Grantham Mayo van Otter...",
"url": "https://www.gurufocus.com/news/2437229/jeremy-granthams-strategic-moves-in-q1-2024-a-closer-look-at-alphabet-incs-impact",
"image_url": "https://s3.amazonaws.com/gurufocus_userupload/1790381686110973952.png",
"language": "en",
"published_at": "2024-05-14T15:01:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NOVN.SW",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.624214,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>Novartis</em> <em>AG</em> (NVS, Financial), reduced by 581,499 shares, marking a -38.07% reduction in shares and a -0.26% impact on the portfolio. The stock traded at an average price of $102.53 during the quarter and has returned 7.17% over the past three months and 5.15% year-to-date.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "9776b5f0-97fa-49a0-b022-671257955c13",
"title": "Arachnoiditis Market To Reach USD 3.3 Billion By 2032 | DataHorizzon Research",
"description": "The arachnoiditis market size was valued at USD 2.4 Billion in 2023 and is expected to reach a market size of USD 3.3 Billion by 2032 at a CAGR of 3.7%....",
"keywords": "DataHorizzon Research, Arachnoiditis, Arachnoiditis Market, Arachnoiditis Market Size, Arachnoiditis Market Growth",
"snippet": "Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) --\n\n\n\nThe growing prevalence of chronic pain is projected to encourage market developments.\n\nThe arachnoid...",
"url": "https://www.globenewswire.com/news-release/2024/05/14/2881083/0/en/Arachnoiditis-Market-To-Reach-USD-3-3-Billion-By-2032-DataHorizzon-Research.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
"language": "en",
"published_at": "2024-05-14T07:17:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "NOVN.SW",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.624674,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Biogen Inc., AbbVie Inc., Amgen Inc., and Merck & Co., Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "c7e23d13-c32d-4d18-a058-9dc1547a426f",
"title": "Uterine Sarcoma Treatment Market To Reach USD 5.9 Billion By 2032 | DataHorizzon Research",
"description": "The uterine sarcoma treatment market size was valued at USD 2.9 Billion in 2023 and is expected to reach a market size of USD 5.9 Billion by 2032 at a CAGR...",
"keywords": "DataHorizzon Research, Uterine Sarcoma Treatment, Healthcare, Uterine Sarcoma Market, Uterine Sarcoma Market Size",
"snippet": "Fort Collins, Colorado, May 14, 2024 (GLOBE NEWSWIRE) --\n\n\n\nRising incidences of uterine sarcoma in the population drive the need for treatment.\n\nThe growth of ...",
"url": "https://www.globenewswire.com/news-release/2024/05/14/2881036/0/en/Uterine-Sarcoma-Treatment-Market-To-Reach-USD-5-9-Billion-By-2032-DataHorizzon-Research.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
"language": "en",
"published_at": "2024-05-14T05:52:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.544544,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMGN",
"name": "Amgen Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.832846,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, <em>Amgen</em> <em>Inc</em>., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.73062,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "., Takeda Pharmaceutical Company Limited, and <em>Gilead</em> <em>Sciences</em>, <em>Inc</em>.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.210217,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVS",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.623062,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMY",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.119354,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.695822,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TAK",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.084023,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.213242,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>plc</em>, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.695096,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 15.695096,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.537043,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, <em>Johnson</em> & <em>Johnson</em>, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZNCF",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.54407,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSEF",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.622375,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TKPHF",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.082005,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMY.BA",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.11729,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ2.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.537073,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, <em>Johnson</em> & <em>Johnson</em>, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DJNJ3.BA",
"name": "Johnson & Johnson",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.537073,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, <em>Johnson</em> & <em>Johnson</em>, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GLAXF",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.211,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>plc</em>, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFED.BA",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 15.695057,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMGN.BA",
"name": "Amgen Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.830816,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, <em>Amgen</em> <em>Inc</em>., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.BA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.209488,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSD.BA",
"name": "NOVARTIS AG",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 20.62218,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRKD.BA",
"name": "MERCK & CO INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 20.695429,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BAYN.BA",
"name": "BAYER AG",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 17.937725,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, <em>Bayer</em> <em>AG</em>, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILDD.BA",
"name": "GILEAD SCIENCES",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 27.633911,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "., Takeda Pharmaceutical Company Limited, and <em>Gilead</em> <em>Sciences</em>, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFECL.SN",
"name": "PFIZER INC",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 15.694885,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.SN",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.694784,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.SN",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.694885,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "4502.T",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.079483,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "4502.S",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "jp",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.0793,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ZEG.DE",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.54347,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BRM.DE",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.114525,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.DE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.695314,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIS.DE",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.726091,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "., Takeda Pharmaceutical Company Limited, and <em>Gilead</em> <em>Sciences</em>, <em>Inc</em>.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6MK.DE",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.69397,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.20781,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GS7.DE",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.20293,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>plc</em>, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMG.DE",
"name": "Amgen Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.824493,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, <em>Amgen</em> <em>Inc</em>., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.PA",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.693062,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZNN.MX",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.543274,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMY.MX",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.1131,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD.MX",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 30.724947,
"sentiment_score": 0.4215,
"highlights": [
{
"highlight": "., Takeda Pharmaceutical Company Limited, and <em>Gilead</em> <em>Sciences</em>, <em>Inc</em>.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE.MX",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.695378,
"sentiment_score": 0.1027,
"highlights": [
{
"highlight": "Some prominent players in the uterine sarcoma treatment market report include <em>Pfizer</em> <em>Inc</em>., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.",
"sentiment": 0.1027,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.MX",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.693104,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, Bristol-Myers Squibb Company, <em>Merck</em> & <em>Co</em>., <em>Inc</em>., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVSN.MX",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.617336,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TAKN.MX",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 37.076054,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.206566,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMGN.MX",
"name": "Amgen Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.822289,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, <em>Amgen</em> <em>Inc</em>., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AZN.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.542885,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSK.L",
"name": "GlaxoSmithKline plc",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.196693,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>GlaxoSmithKline</em> <em>plc</em>, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0A4J.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 19.542688,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., GlaxoSmithKline plc, Johnson & Johnson, <em>AstraZeneca</em> <em>PLC</em>, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0K9E.L",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 20.61627,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0A87.L",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 37.074997,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0Q1G.L",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 32.20643,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NOVN.SW",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "ch",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.624674,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BMYB34.SA",
"name": "Bristol-Myers Squibb Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 46.11878,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, Novartis AG, <em>Bristol</em>-<em>Myers</em> <em>Squibb</em> <em>Company</em>, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LILY34.SA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.210114,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em>, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TAKP34.SA",
"name": "Takeda Pharmaceutical Company Limited",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.08777,
"sentiment_score": 0.5719,
"highlights": [
{
"highlight": "., <em>Takeda</em> <em>Pharmaceutical</em> <em>Company</em> <em>Limited</em>, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?\n\nhttps://bit.ly/4dHtblq\n\nAbout DataHorizzon Research:\n\nDataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "N1VS34.SA",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 20.624472,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "., Eli Lilly and Company, <em>Novartis</em> <em>AG</em>, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, and Gilead Sciences, Inc.\n\nLooking Exclusively For Region/Country Specific Report?",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NOVN.SW",
"total_documents": 3,
"sentiment_avg": 0.10013333956400554
}
]
}
Other details
Exchange
- SIX Swiss Exchange
- equity
- Healthcare
- ch